DEA wants to charge nonregistered meth sellers fee for certification
DEA proposes self-certification fee for sellers of scheduled listed chemical products
As part of its implementation of the Combat Methamphetamine Epidemic Act (CMEA) of 2005, regulated sellers of nonprescription drugs containing ephedrine, pseudoephedrine, or phenylpropanolamine are required to self-certify with DEA. DEA is proposing to charge regulated sellers, who are not DEA registrants, a fee for self-certification. DEA estimates that there are 42,769 pharmacies that are registered with the agency and certified to sell these products and 1,513 pharmacies that are certified but not registered. For each initial application to self certify and for the renewal of each existing self certification, pharmacies must pay a fee of $16. This fee is only required of nonregistered retailers that are not authorized to distribute controlled substances; it is not required of pharmacies that are DEA registrants. Written comments must be postmarked and electronic comments must be sent on or before Nov. 30. Comments may be sent todea.diversion.policy@usdoj.govor filed on-line at
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
